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beta decreased to 116.7 pg/mL. Surprisingly, RT-QuIC assay tested negative at this time. The genetic testing for early onset Alzheimer's disease was all negative. Up to four months after discharge, she has remained cognitively stable. Together, the patient was diagnosed with Alzheimer's disease only, not related to sCJD.
The RT-QuIC exploits the ability of PrP sc to seed the polymerization of protease sensitive recombinant PrP into amyloid fibrils detectable by thioflavin-T fluorescence. 3 This assay identifies cases of prion disease with a sensitivity of 80%-95% and a specificity of 99% when applied in symptomatic CJD patients. Amended criteria indicates probable sCJD when CSF RT-QuIC assay is positive and only one clinical symptom is present. Up to now, only eight cases have rendered a false positive RT-QuIC globally. 4 If the prevalence of a disease is low, the positive predictive value will be low, although the specificity and sensitivity are high. As such, since CJD is a rare disease, the false positive rate may be higher than thought.
In our case, the patient had no symptoms other than dementia or signs of progression. CSF RT-QuIC was positive initially but was negative the second time. The current measurement system may not be entirely reliable. If an automated quantitative system is available, we may avoid even the remote possibility of false positive RT-QuIC test. 5 Caution should be practiced in rendering a fatal diagnosis of sCJD, particularly in the patient with atypical clinical features. We should be mindful that even a highly specific diagnostic tool such as RT-QuIC test does not guarantee the diagnosis of sCJD and that it is safe to double check and repeat the test to allow for an alternative diagnosis until proven otherwise. https://doi.org/10.12779/dnd.2020.19.1.36 
Suspicious RT-QuIC Results in a Dementia

